Analyst rating accuracy & track record
Josh Schimmer is an equity research analyst at Cantor Fitzgerald. Bullish Whales has scored 23 of their stock calls across 12 companies. Their picks beat their sector 36% of the time over the next 12 months, and their price targets were reached — of the time within a year.
Track record
Bullish Whales has scored 23 of Josh Schimmer's stock calls across 12 companies, dating back to 2023. Their rated stocks beat their own sector 36% of the time over the next 12 months. On a typical call, a Schimmer pick returned −4.6% more than its sector over the following year.
Of the scored calls, 23 were bullish (Buy). Most of their coverage sits in Healthcare. Every number on this page is an estimate from our own data. It is for education only and is not investment advice.
Coverage & ratings
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 CMPSCompass Pathways Plc | Buy | $12.00 | May 2025 | +165.6% | Hit |
 RCKTRocket Pharmaceuticals Inc | Buy | $30.00 | May 2025 | −62.8% | Miss |
 SEPNSepterna, Inc. Common Stock | Buy | $25.00 | May 2025 | +153.4% | Hit |
 CGONCG Oncology, Inc. Common stock | Buy | $75.00 | Apr 2025 | +138.2% | Miss |
 AARDAardvark Therapeutics, Inc. Common Stock | Buy | $50.00 | Apr 2025 | −60.5% | Miss |
 ARTVArtiva Biotherapeutics, Inc. Common Stock | Buy | $20.00 | Mar 2025 | +47.2% | Miss |
| AARDAardvark Therapeutics, Inc. Common Stock | Buy | $50.00 | Mar 2025 | −51.1% | Miss |
| SEPNSepterna, Inc. Common Stock | Buy | $50.00 | Feb 2025 | +123.6% | Miss |
| SEPNSepterna, Inc. Common Stock | Buy | $50.00 | Nov 2024 | −5.9% | Miss |
 ZURAZura Bio Limited Class A Ordinary Shares | Buy | — | Oct 2024 | −27.6% | — |
 SPRYARS Pharmaceuticals, Inc | Buy | $30.00 | Oct 2024 | −14.9% | Miss |
 ALECAlector Inc | Buy | — | Sep 2024 | −37.5% | — |
| SPRYARS Pharmaceuticals, Inc | Buy | $30.00 | Sep 2024 | −17.4% | Miss |
| ALECAlector Inc | Buy | — | Sep 2024 | −42.0% | — |
| SPRYARS Pharmaceuticals, Inc | Buy | $30.00 | Sep 2024 | −0.8% | Miss |
 ANNXAnnexon Inc | Buy | — | Sep 2024 | −56.6% | — |
 ARCTArcturus Therapeutics Holdings Inc | Buy | — | Sep 2024 | +0.3% | — |
| SPRYARS Pharmaceuticals, Inc | Buy | $30.00 | Aug 2024 | +18.6% | Miss |
| ZURAZura Bio Limited Class A Ordinary Shares | Buy | — | Aug 2024 | −40.0% | — |
| ARTVArtiva Biotherapeutics, Inc. Common Stock | Buy | $23.00 | Aug 2024 | −66.0% | Miss |
| ZURAZura Bio Limited Class A Ordinary Shares | Buy | — | Jun 2024 | −59.2% | — |
| ZURAZura Bio Limited Class A Ordinary Shares | Buy | — | Jun 2024 | −62.6% | — |
 XENEXenon Pharmaceuticals Inc | Buy | — | Oct 2023 | +5.7% | — |
Josh Schimmer: analyst track record FAQ
Is Josh Schimmer a good stock analyst?
Yes, by track record. Josh Schimmer ranks number 144 of 347 of the analysts Bullish Whales scores, with a BW Score of 36 out of 100. Past results do not guarantee future ones.
What is Josh Schimmer's win rate?
Josh Schimmer's win rate is 36%. Across 23 scored calls, their rated stocks beat their sector 36% of the time over the next 12 months. On a typical call they returned −4.6% more than the sector.
What stocks and sectors does Josh Schimmer cover?
Josh Schimmer covers 12 companies, with the most coverage in Healthcare. See the ratings table above for every scored call and its outcome.
Are Josh Schimmer's price targets accurate?
Josh Schimmer's price targets are reached within 12 months — of the time. The base rate across all analysts Bullish Whales tracks is about 43 percent.
How accurate are Wall Street analyst price targets?
Most analyst price targets are not reached on schedule. Across every target Bullish Whales scores, the stock reaches the target within 12 months only about 43 percent of the time, which is why it helps to compare hit rates analyst by analyst.
Should I follow Josh Schimmer's stock ratings?
Their track record is strong, but no analyst is right every time. Follow the long-term track record rather than any single rating, size your positions to your own risk, and treat this as research, not investment advice.
How does Bullish Whales score analyst accuracy?
Bullish Whales scores every rating on real prices. We enter at the closing price on or after the call date, with no look-ahead, then measure the 12-month return above the stock's sector ETF and check whether the price target was reached. Scores are pulled toward the population average and corrected for testing thousands of analysts at once, so they reflect repeatable skill rather than luck.
How does Josh Schimmer rank among Wall Street analysts?
Josh Schimmer ranks number 144 of 347 by BW Score. We rank analysts by their realized 12-month sector-excess return and require a minimum number of calls so a few lucky picks cannot reach the top.
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.